Onkologie. 2018:12(2):64-67 | DOI: 10.36290/xon.2018.013

Brachytherapy for prostate cancer in light of recent guidelines

Renata Soumarová
Radioterapeutická a onkologická klinika, Fakultní nemocnice Královské Vinohrady, 3. LF UK, Praha

Along with radical prostatectomy and external radiotherapy, brachytherapy for prostate cancer is among the standard treatmentmethods for localized prostate cancer. When compared with the other methods of external radiotherapy, brachytherapy is bestfor the delivery of a high radiation dose to the prostate while sparing the surrounding tissues. Because of its very low morbidityrates, it still remains a current and popular treatment modality. International guidelines for indication and optimal patient selectionare being constantly supplemented and refined.

Keywords: localized prostate cancer, permanent (LDR) brachytherapy, temporary (HDR) brachytherapy

Published: April 1, 2018  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Soumarová R. Brachytherapy for prostate cancer in light of recent guidelines. Onkologie. 2018;12(2):64-67. doi: 10.36290/xon.2018.013.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Peeters ST, Heemsbergen WD, Koper PC, et al. Dose-response in radiotherapy for localized prostate cancer: results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy. J Clin Oncol 2006; 24: 1990-1996. Go to original source... Go to PubMed...
    2. Ash D, Flynn A, Battermann J, et al. ESTRO/EAU/EORTC recommendations on permanent seed implantation for localized prostatecancer. Radiother Oncol. 2000; 57(3): 315-321. Go to original source... Go to PubMed...
    3. Kovács G, Pötter R, Loch T, et al. GEC/ESTRO-EAU recommendations on temporary brachytherapy using stepping sources for localised prostate cancer. Radiother Oncol. 2005; 74(2): 137-148. Go to original source... Go to PubMed...
    4. Hoskin PJ, Colombo A, Henry A, et al. GEC/ESTRO recommendations on high dose rate afterloading brachytherapy for localised prostate cancer: an update Radiother Oncol. 2013; 107(3): 325-332. Go to original source... Go to PubMed...
    5. http://uroweb.org/guideline/prostate-cancer/
    6. Yamada Y, Rogers L, Demanes DJ, et al. American Brachytherapy Society. American Brachytherapy Society consensus guidelines for high-dose-rate prostate brachytherapy. Brachytherapy. 2012; 11(1): 20-32. Go to original source... Go to PubMed...
    7. Davis BJ, Horwitz EM, Lee WR, et al. American Brachytherapy Society. American Brachytherapy Society consensus guidelines for transrectal ultrasound-guided permanent prostate brachytherapy. Brachytherapy. 2012; 11(1): 6-19. Go to original source... Go to PubMed...
    8. Wojcieszek P, Białas B. Prostate cancer brachytherapy: guidelines overview. J Contemp Brachytherapy. 2012; 4(2): 116-120. Go to original source... Go to PubMed...
    9. Davis BJ, Taira AV, Nguyen PL, et al. ACR appropriateness criteria: Permanent source brachytherapy for prostate cancer. Brachytherapy. 2017; 16(2): 266-276. Go to original source... Go to PubMed...
    10. Chin J, Rumble RB, Kollmeier M, et al. Brachytherapy for Patients With Prostate Cancer: American Society of Clinical Oncology/Cancer Care Ontario Joint Guideline Update. J Clin Oncol. 2017; 35(15): 1737-1743. Go to original source... Go to PubMed...

    Return to the content


    Oncology

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.